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Infusion of D1 Dopamine Receptor
Agonist into Medial Frontal Cortex
Disrupts Neural Correlates of Interval
Timing
Krystal L. Parker, Rafael N. Ruggiero and Nandakumar S. Narayanan*
Neurology, University of Iowa, Iowa City, IA, USA
Medial frontal cortical (MFC) dopamine is essential for the organization of behavior in
time. Our prior work indicates that blocking D1 dopamine receptors (D1DR) attenuates
temporal processing and low-frequency oscillations by MFC neuronal networks. Here we
investigate the effects of focal infusion of the D1DR agonist SKF82958 into MFC during
interval timing. MFC D1DR agonist infusion impaired interval timing performance without
changing overall firing rates of MFC neurons. MFC ramping patterns of neuronal activity
that reflect temporal processing were attenuated following infusion of MFCD1DR agonist.
MFC D1DR agonist infusion also altered MFC field potentials by enhancing delta activity
between 1 and 4Hz and attenuating alpha activity between 8 and 15Hz. These data
support the idea that the influence of D1-dopamine signals on frontal neuronal activity
adheres to a U-shaped curve, and that cognition requires optimal levels of dopamine in
frontal cortex.
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INTRODUCTION
Frontal dopamine signaling is crucial for memory and cognition (Goldman-Rakic, 1998).
Dysfunction of medial frontal dopamine is involved in diseases such as ADHD, schizophrenia,
and Parkinson’s disease (Cools et al., 2001; Abi-Dargham et al., 2002; Bellgrove et al., 2005;
Narayanan et al., 2013a). Cognition requires optimal levels of frontal dopamine signaling (Cools
andD’Esposito, 2011). There are twomajor classes of dopamine receptors: D1 andD2. Of these, D1-
type dopamine receptors (D1DR) have been specifically implicated in cognition (Goldman-Rakic
et al., 2004; Kim et al., 2015). Both agonists and antagonists of D1DRs impair neural correlates of
cognitive processes such as working memory and attention (Williams and Goldman-Rakic, 1995;
Granon et al., 2000; Vijayraghavan et al., 2007).
Here, we study howmanipulating D1DRs influences neural activity during timing tasks. Timing
is an executive function that requires working memory for temporal rules as well as attention
to the passage of time (Parker et al., 2013a; Merchant and de Lafuente, 2014). Timing is well-
suited to study human diseases of cognition because it involves common dopamine-dependent
frontal cortical mechanisms in humans and rodents (Merchant et al., 2008; Narayanan et al.,
2013b; Parker et al., 2013a, 2015; Merchant and de Lafuente, 2014). We focus on the MFC because
rodents lack lateral frontal regions and because of MFC’s homologies between rodents and humans
Abbreviations:MFC, Medial frontal cortex; D1DR, D1 dopamine receptors; PD, Parkinson’s disease.
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(Laubach, 2011). Blocking D1DRs in the MFC impairs
performance on interval timing tasks, in which subjects initiate
a motor response several seconds after an instructional cue
(Narayanan et al., 2012). In MFC, there are two prominent
neuronal correlates of temporal processing: (1) ramping activity,
or neuronal firing that consistently changes over the temporal
interval (Durstewitz, 2003; Kim et al., 2013; Parker et al., 2014;
Xu et al., 2014) and (2) low-frequency oscillations around∼4Hz
triggered by the instructional stimuli (Parker et al., 2014, 2015).
Blocking D1DRs attenuates both ramping activity and attenuates
∼4Hz oscillationsHz (Parker et al., 2014). It is unclear how these
two correlates of medial frontal cortex activity are influenced by
MFC D1DR agonists. Previous data demonstrating that D1DR
agonists impair cognitive performance and neuronal correlates
of cognition in frontal cortex predict that D1DR agonists should
attenuate both ramping activity and∼4Hz oscillations.
To test this idea, we recorded neural activity and field
potentials from MFC following infusion of SKF82958 (Gilmore
et al., 1995), a D1DR agonist, into MFC of animals performing
an interval timing task. We report that focal infusion of
D1DR agonist attenuates MFC ramping neuronal activity and
increases cue-dependent delta activity. These data support the
idea that temporal processing by single neurons, like mnemonic
processing, requires optimal levels of frontal D1DR signaling.
MATERIALS AND METHODS
Seven male Long-Evans rats (aged 2 months; 200–225 g)
were trained to perform an interval timing task. Animals
were motivated by water restriction, while food was available
ad libitum. Rats consumed 10–15mL of water during each
behavioral session and additional water (5–10mL) was provided
1–3 h after each behavioral session in the home cage. Single
housing and a 12 h light/dark cycle were used; all experiments
took place during the light cycle. Rats were maintained at ∼90%
of their free-access body weight during the course of these
experiments and received one day of free access to water per
week. All procedures were approved by the Animal Care and Use
Committee at the University of Iowa.
Rats were trained in interval timing tasks using standard
operant procedures described in detail previously (Parker et al.,
2014, 2015). First, animals learned to make operant lever
presses to receive liquid rewards. After fixed-ratio training,
animals were trained in a 12 s fixed-interval timing task in
which rewards were delivered for responses after a 12 s interval
(Figure 1A). Rewarded presses were signaled by a click and
an “off” houselight. Each rewarded trial was followed by an
intertrial interval of 6–12 s, randomly chosen. Intertrial intervals
concluded with an “on” houselight signaling the beginning of
the next trial. Early responses occurring before 12 s were not
reinforced. The houselight was turned on at trial onset and lasted
until the onset of the intertrial interval.
Interval timing performance was evaluated by the timing
efficiency or the number of lever presses occurring in the 11–
12 s, timed interval in comparison to all lever presses occurring
from 1 to 12 s of the trial. Curvature was also used to evaluate
performance during the interval timing task. Curvature indexes
FIGURE 1 | (A) Interval timing task. Subjects estimate a 12 s interval starting
with the onset of a discriminative stimulus by making a motor response;
multiple responses per trial are permitted. (B) Cannula locations in the MFC
were reconstructed from histological sections; cannulae are marked by blue
circles, and electrode locations by red circles.
increase as animals’ responses are guided by time and measure
the deviation from the cumulative response record of a straight
line (Fry et al., 1960; Parker et al., 2015). Curvature of time-
response histograms is a robust measure of animals’ timing as it is
independent of response rate as responses are controlled by time
(Caetano and Church, 2009; Parker et al., 2014).
Rats trained in the 12 s interval timing task were implanted
with amicrowire electrode array and a 33-gauge infusion cannula
(Plastics One) in the MFC according to procedures described
previously (Parker et al., 2014). Briefly, animals were anesthetized
using Ketamine (100mg/kg) and Xylazine (10mg/kg). A surgical
level of anesthesia was maintained with ketamine supplements
(10mg/kg). Under aseptic surgical conditions, the scalp was
retracted, and the skull was leveled between bregma and lambda.
A single craniotomy was drilled over the area above the MFC and
four holes were drilled for skull screws. A microelectrode array
was implanted in MFC (coordinates from bregma: AP: +3.2,
ML ± 1.2, DV −3.5 @ 12◦ in the lateral plane). Electrode
ground wires were wrapped around the skull screws. The
infusion cannula was then lowered to target the neurons being
recorded (coordinates from bregma: AP: +0.3, ML ± 1.0,
DV−4.6 @ 40◦ in the lateral plane; targeting bregma coordinates
AP +3.2, ML ± 1.0, DV −3.4 in the center of the recording
array). The craniotomy was sealed with cyanoacrylate (“SloZap,”
Pacer Technologies, Rancho Cucamonga, CA) accelerated by
“ZipKicker” (Pacer Technologies), and methyl methacrylate (i.e.,
dental cement; AM Systems, Port Angeles, WA). Following
implantation, animals recovered for one week before being
reacclimatized to behavioral and recording procedures.
At the beginning of recording experiments, rats
received a saline infusion into the MFC ∼45min prior to
neurophysiological recording according to procedures described
previously (Parker et al., 2013b, 2014). On the subsequent day
rats received an infusion of the D1DR agonist SKF82958 into
the MFC. Infusion was conducted by inserting an injector into
the guide cannula and 0.5µL of infusion fluid was delivered
at a rate of 30µL/h (0.5µL/min) via a syringe infusion pump
(KDS Scientific, Holliston, MA). After injections were complete,
the injector was left in place for 2min to allow for diffusion.
Statistical comparisons between saline and MFC SKF82958
infusion sessions made no assumption that identical neurons
were recorded on subsequent days.
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Neuronal ensemble recordings in the MFC were made
using a multi-electrode recording system (Plexon, Dallas, TX).
Putative single neuronal units were identified on-line using
an oscilloscope and audio monitor. The Plexon off-line sorter
was used to analyze the signals after the experiments and to
remove artifacts. Spike activity was analyzed for all cells that
fired at rates above 0.1Hz. Statistical summaries were based
on all recorded neurons. No subpopulations were selected
or filtered out of the neuron database. Wide-band signals
were recorded using wide-band boards with bandpass filters
between 0.07 and 8000Hz and sampled at 40,000Hz. Principal
Component Analyses (PCA) and waveform shapes were used
for spike sorting. Single units were identified as having (1)
consistent waveform shape, (2) separable clusters in PCA
space, (3) a consistent refractory period of at least 2ms in
interspike interval histograms, and (4) consistent firing rates
around behavioral events (as measured by a runs test of
firing rates across trials around behavioral events; neurons
with |z| scores > 4 were considered “nonstationary” and were
excluded). Analysis of neuronal activity and quantitative analysis
of basic firing properties were carried out using NeuroExplorer
(Nex Technologies, Littleton, MA), and with custom routines
for MATLAB. Peri-event rasters and average histograms were
constructed around light on, lever release, lever press, and lick.
Microwire electrode arrays were comprised of 16 electrodes. In
each animal, one electrode without single units was reserved
for local referencing, yielding 15 electrodes per rat. Local field
potentials (LFPs) were recorded from 4 of these electrodes per
rodent. LFP channels were analog filtered between 0.7 and 100Hz
online, sampled at 1000Hz and recorded in parallel with single
unit channels using a wide-band board. Consistent with our prior
work, although examples of individual neurons are shown under
different drug conditions (control and MFC D1DR agonist), our
statistical analyses assume that these populations of neurons are
independent (Narayanan and Laubach, 2006, 2008; Narayanan
et al., 2013b).
We defined ramping activity as firing rate that progressed
uniformly over the interval. We quantified this in two ways:
linear regression and PCA. Ramping neurons are described as
those with a significant relationship of firing rates over trials
vs. time in a linear regression model (Kim et al., 2013). For
regression, firing rates were binned into 2 s bins. Secondly, PCA
was used to identify dominant patterns of neuronal activity using
orthogonal basis functions from peri-event histograms during
the 12 s interval (Paz et al., 2005; Narayanan and Laubach,
2009; Bekolay et al., 2014; Narayanan and Laubach, 2014). All
neurons from 6 animals per session (control and MFC D1DR
agonist sessions) were included in PCA, and the first 500ms
of the interval was excluded due to stimulus-related activity.
The same principal components were projected onto control
and MFC SKF sessions, and the weights were compared via
a t-test (Chapin and Nicolelis, 1999; Narayanan and Laubach,
2014).
Time-frequency calculations were computed using custom-
written Matlab routines (Cavanagh et al., 2009). Time-frequency
measures were computed by multiplying the fast Fourier
transformed (FFT) power spectrum of LFP data with the FFT
power spectrum of a set of complex Morlet wavelets (defined
as a Gaussian-windowed complex sine wave: ei2pi tf e
−
t2
2xσ2 ,
where t is time, f is frequency (which increased from 1 to
50Hz in 50 logarithmically spaced steps), and defines the
width (or “cycles”) of each frequency band, set according
to 4/(2pif)), and taking the inverse FFT. The end result of
this process is identical to time-domain signal convolution,
and it resulted in: (1) estimates of instantaneous power (the
magnitude of the analytic signal), defined as Z[t] (power time
series: p(t) = real[z(t)]2 + imag[z(t)]2); and, (2) phase (the
phase angle) defined as = arctan(imag[z(t)]/real[z(t)]). Each
epoch was then cut in length surrounding the event of interest
(−500 to +2000ms). Power was normalized by conversion
to a decibel (dB) scale (10∗log10[power(t)/power(baseline)])
from a pre-stimulus baseline of −500 to −300ms, allowing a
direct comparison of effects across frequency bands. Statistical
significance was computed via a paired t-test comparing saline
and D1DR agonist sessions in 3 three frequency bands, delta
(1–4Hz), theta (4–8Hz), and alpha (8–15Hz).
When experiments were complete, rats were sacrificed by
injections of 100mg/kg sodium pentobarbital, and transcardially
perfused with 10% formalin. Brains were post fixed in a solution
of 10% formalin and 20% sucrose before being sectioned on
a freezing microtome. Brain slices were mounted on gelatin-
subbed slides and stained for cell bodies using DAPi. Histological
reconstruction was completed using post mortem analysis of
electrode and cannula placements and confocal microscopy in
each animal. These data were used to determine electrode and
cannula placement within the MFC.
RESULTS
We trained seven rats to perform an interval timing task and
implanted recording electrodes and an infusion cannula into the
MFC (Figures 1A,B). After recovery from surgery, we focally
infused the D1DR agonist SKF82958 into the MFC (MFC D1DR
agonist sessions) prior to neuronal recordings during interval
timing tasks. Compared to saline sessions, rodents had similar
numbers of lever presses in MFC D1DR agonist infusion sessions
(153.2 ± 16.8 vs. 141.5 ± 24.7 in saline sessions; Figure 2A),
and acquired similar numbers of rewards (82.8 ± 5.3 vs. 75.8 ±
12.1 in saline sessions Figure 2B). MFC D1DR agonist infusion
significantly decreased how efficiently animals responded at
interval end [% of responses between 11 and 12 s; 0.08 ± 0.2 vs.
0.20 ± 0.03 in saline sessions; t(5) = 3.4, p < 0.02; Figure 2D].
Interval timing performance was measured using a curvature
index where a higher curvature corresponds to higher deviations
from a straight line (24). Here, we found a flatter curvature
of time-response histogram in MFC D1DR agonist sessions in
comparison to saline sessions [0.23 ± 0.04 vs. 0.32 ± 0.03; t(5) =
2.63, p < 0.05; Figure 2C]. Taken together, these data indicate
that focal MFC D1DR agonist decreases how efficiently animals
guide their responses in time without changing lever pressing or
motivation (Figure 2E).
In seven animals, we recorded 41 neurons in sessions with
MFC D1DR agonist, and 47 neurons in saline sessions. Focal
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FIGURE 2 | Focal infusion of MFC D1 agonist into the MFC decreases
the efficiency of interval timing without changing other aspects of
behavior. MFC D1DR agonists (green) did not change the number of overall
lever presses (A) or the number of rewards (B) when compared to saline
sessions (blue). (C) Curvature indices of time-response histograms we
significantly reduced in MFC D1DR agonist sessions compared to control
sessions, and (D) MFC D1DR agonist decreased how efficiently animals timed.
(E) Time-response histograms during interval timing sessions show less
accurately timed lever pressing in animals following infusion of MFC D1DR
agonist (in 7 animals). Asterisks represent significance at p < 0.05 via a t-test.
MFC SKF82958 infusion did not change overall firing rate (2.9±
0.5 vs. 3.6 ± 0.9Hz in saline sessions). We identified stimulus-
related neurons and neurons related to lever pressing by paired
t-tests of firing rate before and after stimulus and lever press
(Parker et al., 2014). By these criteria, similar fractions of MFC
neurons were stimulus-related in MFC D1DR agonist sessions
compared to saline sessions (stimulus: 3 vs. 4 in saline sessions;
press: 5 vs. 4 in saline sessions). These results provide evidence
that SKF82958 did not change the basic neuronal properties
of MFC.
Ramping activity, or neuronal activity that consistently
increases or decreases over a temporal interval, is a key correlate
of temporal processing in MFC (Figure 3A) (Durstewitz, 2003;
Kim et al., 2013). Our recent work has shown that MFC D1DR
blockade attenuates ramping activity (Parker et al., 2014). Here
we investigated how MFC D1DR agonists influence ramping
activity. We identified ramping activity using linear regression to
identify neurons with a significant linear fit. Only 1 neuron had
a significant linear fit in MFC D1DR agonist sessions, compared
with 7 neurons in saline sessions (2 vs. 15% in saline sessions;
χ
2 = 4.3, p < 0.04; Figure 3B). When neural data was shuﬄed
in time, no significant differences in ramping neurons were
observed (3 neurons/6% in saline sessions vs. 2 neurons/5% in
SKF; χ2 = 0.09, p < 0.76). Ramping activity is also readily
identified by principal component analysis, in which ramping
components are PC1 (Narayanan and Laubach, 2009; Bekolay
et al., 2014; Parker et al., 2014). Consistent with prior work,
ramping activity was PC1 and explained 28% of variance among
neuronal ensembles in saline sessions (Figure 3C). PC1 loaded
FIGURE 3 | MFC D1DR agonist attenuates ramping activity. (A) Example
of an MFC ramping neuron recorded in control (blue) sessions. In green, the
same putative neuron from the control session is shown in MFC D1DR agonist
sessions. Top plot is a raster plot depicting the activity of a single neuron
selected from each condition. Each row is a trial from the experiment and each
dot is an action potential from a single neuron. (B) There was significantly less
ramping activity in MFC D1DR agonist sessions, as identified by the number of
neurons with a significant linear fit via regression. Statistical comparisons
assumed that independent populations were recorded in control and D1DR
blockade sessions. (C) Principal component analysis in control sessions
revealed that ramping activity was the most prominent pattern of neural activity
among MFC neurons (PC1). (D) To directly compare ramping activity, we
projected PCs from control sessions onto MFC D1 agonist sessions. PC1
explained significantly less variance in MFC D1DR agonist sessions, while PC2
and 3 were unchanged. Asterisk represents significance at p < 0.05 via a
t-test. All statistics treated each session independently. Taken together, these
data suggest that MFC D1DR agonist attenuates ramping activity of neurons.
more significantly onto saline sessions compared to MFC D1DR
agonist sessions [Figure 3D; t(86) = 2.3, p < 0.03]. Taken
together, these data indicate that MFC D1DR agonists attenuated
ramping activity in MFC.
During timing tasks, there is a burst of ∼4Hz field potential
activity after the instructional stimulus during timing tasks
(Parker et al., 2014, 2015). This activity is dependent on MFC
dopamine and attenuated with D1DR blockade (Parker et al.,
2014, 2015). We examined how this activity changed in MFC
D1DR agonist sessions among 17 LFP channels across 7 animals.
Consistent with prior work in saline sessions, the instructional
stimulus was followed by a burst of delta (1–4Hz), theta (4–8Hz)
and alpha (8–15Hz) activity (Figures 4A,B). In MFC D1DR
agonist sessions, delta activity increased [t(16) = 2.7, p < 0.02;
1–4Hz 0–1 s after the cue], theta activity did not change (4–8Hz
0–1 s after the cue), and alpha activity was attenuated [t(16) = 3.1,
p < 0.01; 8–12Hz 0–1 s after the cue], when compared to saline
sessions (Figures 4C,D). Taken together, these data indicate
that D1DR agonist SKF82958 in MFC disrupts performance of
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FIGURE 4 | MFC D1DR agonists influence oscillatory patterns of MFC LFP during interval timing tasks. (A) Event-related potentials from all LFP channels in
7 rodents (17 channels) revealed a stimulus-triggered peak the MFC after stimulus onset. MFC ERP is unaffected by MFC D1DR agonists. (B) Time-frequency analysis
revealed a burst of activity from 4 to 15Hz following the onset of the cue. (C,D) Infusions of MFC D1DR agonist significantly increased delta activity between 1 and
4Hz and attenuated alpha activity between 8 and 15Hz while theta activity was unaffected. Asterisk represents significance at p < 0.05 via a t-test.
interval timing tasks as well as neuronal correlates of temporal
processing in MFC.
DISCUSSION
In the presentmanuscript, we recordedMFC neuronal ensembles
while focally infusing the D1DR agonist SKF82958 into MFC
during performance of an interval timing task. We found that
MFC SKF82958 infusion decreased the efficiency of animals’
responses during interval timing, attenuated MFC ramping
activity, and altered MFC field potentials by enhancing delta
activity between 1 and 4Hz and attenuating alpha activity
between 8 and 15Hz. These data, in combination with our prior
work, suggest that optimal frontal D1DR signaling is central
to the temporal control of action (Parker et al., 2013b, 2014,
2015).
Combined with our work showing that MFC D1DR blockade
disrupts MFC activity, our result is consistent with the idea
that fluid cognition requires optimal dopamine in frontal cortex
(Goldman-Rakic, 1998). This “U-shaped curve” has been shown
for D1DR signaling for cognitive tasks in rats and primates (Zahrt
et al., 1997; Granon et al., 2000; Vijayraghavan et al., 2007). In
particular, both performance of working memory tasks as well
as mnemonic delay activity of frontal neurons requires optimal
frontal D1DR (Vijayraghavan et al., 2007). Optimal levels of
dopamine are critical for efficient neural transmission in frontal
cortex (Kroener et al., 2009).
We extend this line of work to two neuronal correlates of
interval timing: ramping activity and low-frequency oscillations.
Ramping activity encodes temporal processing in parietal,
temporal, and frontal brain regions (Reutimann et al., 2004;
Janssen and Shadlen, 2005; Narayanan and Laubach, 2009; Kim
et al., 2013). Our results suggest that ramping activity predicts
response time on a trial-by-trial basis (Parker et al., 2014)
and like delay-activity during working memory tasks, depends
on optimal MFC D1DR dopamine signaling. With both MFC
D1DR antagonist SCH23390 andMFC D1DR agonist SKF82958,
ramping activity is broadly attenuated, clearly demonstrating
that ramping signals in MFC adhere to the same U-shaped
curve as mnemonic activity during working memory tasks
TABLE 1 | Summary of MFC spectral activity in delta, theta and alpha
bands 0–1 s after cue onset.
Delta Theta Alpha
Saline −0.07± 0.17 0.81±0.22 1.15± 0.29
SCH 0.32± 0.13 −0.11±0.30 −0.10± 0.33
SKF 0.24± 0.70 0.82±0.22 0.50± 0.09
SCH data are extracted from previously published dataset in Parker et al. (2014).
from primate lateral frontal cortex (Goldman-Rakic et al., 2004;
Vijayraghavan et al., 2007). It is unclear, however, why ramping
activity is attenuated. During timing tasks, dopamine neurons
phasically fire to reward-predictive stimuli at the beginning of
the task (Kobayashi and Schultz, 2008). However, endogenous,
tonic dopamine levels can also affect frontal function (Kroener
et al., 2009; Cools and D’Esposito, 2011). Future studies will
manipulate dopamine neurons while recording from frontal
neuronal ensembles to address this issue.
While ramping activity adheres to a U-shaped curve,
dopamine’s influence on spectral properties of MFC field
potentials is more complex (Table 1). Delta activity was increased
with MFC D1 agonists, while alpha was attenuated and theta
was unchanged. MFC ramping neurons are coherent with∼4Hz
activity (Narayanan et al., 2013b; Parker et al., 2014). In this study,
delta activity was increased but ramping activity did not improve,
indicating that coupling between ramping neurons and ∼4Hz
activity might also depend on optimal D1DR signaling. Our data
suggest that only alpha activity strictly follows a U-shaped curve
(Figure 3; Table 1). Alpha activity in frontal cortex has been
associated with top-down processing (Sauseng et al., 2005), and
the decreased alpha we see in this study may be reflective of
decreased executive control in MFC D1DR agonist sessions.
Low-frequency oscillations are a key mechanism of cognitive
control (Cavanagh and Frank, 2014). Rodents and humans
have common low-frequency activity in delta, theta, and alpha
bands during cognitive tasks (Narayanan et al., 2013b; Parker
et al., 2015). These spectral activities require MFC dopamine
(Parker et al., 2015). Because low-frequency oscillations can be
readily observed with scalp-EEG, finding that they are sensitive
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to optimal frontal dopamine are of particular translational
significance. In humans with Parkinson’s disease, frontal
dopamine may be facilitated early in the disease and profoundly
influenced by the treatment (Cools et al., 2001, 2010). Several
human diseases, such as schizophrenia, ADHD, and drug
addiction (Abi-Dargham et al., 2002; Heijtz et al., 2007) involve
dysfunctional frontal dopamine signaling. Our findings predict
that in human diseases with disrupted frontal D1DR dopamine
signaling, spectral activity in MFC will also be disrupted (Parker
et al., 2015).
These data involve several limitations. First, we administered
a pharmacological agonist with a complex receptor profile
(Gilmore et al., 1995). Dopamine signaling is complex and
depends on state, history, and network properties (Seamans
and Yang, 2004). MFC D1DR agonists also likely cause rapid
receptor internalization (Ryman-Rasmussen et al., 2005). D1DR
are G-Protein receptors with diverse intracellular targets via
cAMP (Kim et al., 2015). D1DR signaling can potentiate inputs
of local cortical networks onto pyramidal neurons (Yang and
Seamans, 1996). Thus, the functional outcome of MFC D1DR
agonists on neuronal activity is quite complex. When specifically
stimulating frontal neurons expressing D1DRs, interval timing
performance is not disrupted but slightly enhanced (Narayanan
et al., 2012). Future studies will explore the detailed action
of D1DRs signaling aimed at new therapies for human
diseases.
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